CD14 is an essential mediator of LPS-induced airway disease.
about
Role of CD14 in a mouse model of acute lung inflammation induced by different lipopolysaccharide chemotypes.Modulation of SCF beta-TrCP-dependent I kappaB alpha ubiquitination by hydrogen peroxide.Human resistin promotes neutrophil proinflammatory activation and neutrophil extracellular trap formation and increases severity of acute lung injuryReducing LPS content in cockroach allergens increases pulmonary cytokine production without increasing inflammation: a randomized laboratory study.Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase.Inhibition of neutrophil apoptosis by PAI-1.Toll-like receptor 4 engagement inhibits adenosine 5'-monophosphate-activated protein kinase activation through a high mobility group box 1 protein-dependent mechanismMonocytes control second-phase neutrophil emigration in established lipopolysaccharide-induced murine lung injury.Vitronectin inhibits efferocytosis through interactions with apoptotic cells as well as with macrophagesEndotoxin receptor CD14 in PiZ alpha-1-antitrypsin deficiency individuals.HMGB1 promotes neutrophil extracellular trap formation through interactions with Toll-like receptor 4Racial differences in the association of CD14 polymorphisms with serum total IgE levels and allergen skin test reactivityUnfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in ratsSignal transduction pathways linking the activation of alveolar macrophages with the recruitment of neutrophils to lungs in chronic obstructive pulmonary disease.Role of CD14 in lung inflammation and infection.siRNA targeting mCD14 inhibits TNF-α, MIP-2, and IL-6 secretion and NO production from LPS-induced RAW264.7 cells.CD14 gene silencing alters the microRNA expression profile of RAW264.7 cells stimulated by Brucella melitensis infection.A potential role for macrophages in maintaining lipopolysaccharide-induced subacute airway inflammation in rats.Nuclear factor-kappaB activation in airway epithelium induces inflammation and hyperresponsiveness.Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and miceChanges in Expression of the Membrane Receptors CD14, MHC-II, SR-A, and TLR4 in Tissue-Specific Monocytes/Macrophages Following Porphyromonas gingivalis-LPS Stimulation.
P2860
Q33564362-E27130F4-F3FB-46B2-BB03-42925993F073Q33594018-87BC0D13-578F-4E7C-BF13-9AE133AD7056Q33600997-A3C5DC03-5348-4BFF-A62C-A4347C10B91EQ33827591-F28EC19B-C2A1-4A1C-83A5-099286D93D21Q34236772-CF5BAC88-B354-4DC3-A88D-8ACA4B0CC5E9Q35159761-33F10A49-BC3C-4067-AB0C-691AFA0CF161Q36071738-FA1FCAD8-EEA9-4CE9-9C64-95112F2BB0A3Q36345279-C19A27D9-4469-4569-B2A2-706A940F64C6Q36625153-3F7D6DC7-FD39-47A8-9383-F758E274505FQ36661493-1CCA920D-FEA1-470C-BE76-CF08DA9088A5Q36699968-D1871FE1-B0E7-4B27-A1DD-C00E5C81756DQ36975259-F125DFBC-6293-43B2-AF4C-B2AB0602A383Q37160876-63003344-47F1-459F-82D5-0EEE947FFB92Q37618178-BF55B991-467C-4059-AF6E-1F9A554A50FDQ37710762-EFE534D0-37F2-41B8-A63E-51664F1517D9Q39169211-5A50B6B0-25ED-4852-9BDB-644D79F90AECQ39407691-5AC9E15C-7C8F-4550-9DAA-F9C090D50FC8Q41298695-104C9757-C33E-4FFD-A7C4-D24B80DD3B1FQ41923388-12EC00F8-ABE3-42F3-9D6F-AA89F63EE2BFQ41984558-4141B34B-0288-472B-BA7C-39FE2B713ED8Q47576037-3913771C-D5EC-4CB9-9E4C-A20A6D3B46C2
P2860
CD14 is an essential mediator of LPS-induced airway disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
CD14 is an essential mediator of LPS-induced airway disease.
@en
CD14 is an essential mediator of LPS-induced airway disease.
@nl
type
label
CD14 is an essential mediator of LPS-induced airway disease.
@en
CD14 is an essential mediator of LPS-induced airway disease.
@nl
prefLabel
CD14 is an essential mediator of LPS-induced airway disease.
@en
CD14 is an essential mediator of LPS-induced airway disease.
@nl
P2093
P2860
P1476
CD14 is an essential mediator of LPS-induced airway disease.
@en
P2093
David A Schwartz
David M Brass
Erin McElvania-Tekippe
Imtaz Hossain
John W Hollingsworth
Stavros Garantziotis
P2860
P304
P356
10.1152/AJPLUNG.00282.2006
P577
2007-03-23T00:00:00Z